Dr. Martens plc
DOCMF · OTC
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | – | $1 |
| - Cash | $0 | $0 | – | $0 |
| + Debt | $0 | $0 | – | $0 |
| Enterprise Value | $1 | $1 | – | $1 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | 42.6% | – |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | 54.6% | – | 65.7% | 64% |
| EBITDA | $0 | – | $0 | -$0 |
| % Margin | 11.7% | – | 24.8% | -1.4% |
| Net Income | -$0 | – | $0 | -$0 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS Diluted | -0.014 | – | 0.034 | -0.022 |
| % Growth | – | – | 253.6% | – |
| Operating Cash Flow | -$0 | – | $0 | $0 |
| Capital Expenditures | -$0 | – | -$0 | -$0 |
| Free Cash Flow | -$0 | – | $0 | $0 |